Aurora Spine to Participate at EFORT in London

Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it will be participating at the 2014 European Federation of National Associations of Orthopaedics and Traumatology (EFORT) Conference from Wednesday, June 4th to Friday, June 6th, 2014, at the ExCeL London in London, United Kingdom, booth # J10-11.

"Aurora Spine is pleased to exhibit our innovative technologies and minimally invasive product portfolio at EFORT in London," said Sven Claes, International Product Director of Aurora Spine. "This year we will focus on the Zip Ultra™ minimally invasive ISP fusion system in combination with the TiNano™ interbody spinal fusion cage portfolio. The TiNano interbody cages are made out of PEEK and coated with Titanium, enhancing bone contact."

The theme of this year's conference is "patient safety". The EFORT education committee has created a program covering topics from basic research to daily practice of orthopedics and trauma.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of the Aurora Spine's products. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Eric Fronk

Chief Financial Officer

(760) 424-2004

Christian Flores